BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$85.60+0.56 (+0.66%)
Close on Nov 13, 2026Market cap $21.50BP/E –Yield –
BioNTech operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -49.0%, against -47.8% the year before. The highest annual figure on record is 80.5% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -49.0% | −1.2 |
| FY2024 | Dec 31, 2024 | -47.8% | −65.9 |
| FY2023 | Dec 31, 2023 | 18.1% | −55.0 |
| FY2022 | Dec 31, 2022 | 73.0% | −7.5 |
| FY2021 | Dec 31, 2021 | 80.5% | +97.6 |
| FY2020 | Dec 31, 2020 | -17.1% | +150.0 |
| FY2019 | Dec 31, 2019 | -167.1% | −124.9 |
| FY2018 | Dec 31, 2018 | -42.2% | +57.3 |
| FY2017 | Dec 31, 2017 | -99.5% | – |
See a number that looks wrong?